Literature DB >> 19865117

Gene therapy deserves a fresh chance.

.   

Abstract

Mesh：

Year:  2009        PMID： 19865117     DOI： 10.1038/4611173a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Orthopedic gene therapy--lost in translation?

Authors:  C H Evans; S C Ghivizzani; P D Robbins
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 2.  Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Authors:  Bipulendu Jena; Gianpietro Dotti; Laurence J N Cooper
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

Review 3.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

Review 4.  Getting arthritis gene therapy into the clinic.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Nat Rev Rheumatol       Date:  2010-12-07       Impact factor: 20.543

Review 5.  Cell-based therapy for the deficient urinary sphincter.

Authors:  Melanie L Hart; Katharina M H Neumayer; Martin Vaegler; Lisa Daum; Bastian Amend; Karl D Sievert; Simone Di Giovanni; Udo Kraushaar; Elke Guenther; Arnulf Stenzl; Wilhelm K Aicher
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 6.  Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

Authors:  Niclas E Bengtsson; Jane T Seto; John K Hall; Jeffrey S Chamberlain; Guy L Odom
Journal:  Hum Mol Genet       Date:  2015-10-08       Impact factor: 6.150

Review 7.  A transposon and transposase system for human application.

Authors:  Perry B Hackett; David A Largaespada; Laurence J N Cooper
Journal:  Mol Ther       Date:  2010-01-26       Impact factor: 11.454

Review 8.  Catching the engram: strategies to examine the memory trace.

Authors:  Masanori Sakaguchi; Yasunori Hayashi
Journal:  Mol Brain       Date:  2012-09-21       Impact factor: 4.041

9.  Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progression.

Authors:  Amrendra K Ajay; Ankur K Upadhyay; Sandeep Singh; Maleppillil V Vijayakumar; Ratna Kumari; Vimal Pandey; Ramanamurthy Boppana; Manoj K Bhat
Journal:  Mol Cancer       Date:  2010-07-31       Impact factor: 27.401

10.  Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells.

Authors:  N Zhao; J M Fogg; L Zechiedrich; Y Zu
Journal:  Gene Ther       Date:  2010-10-21       Impact factor: 5.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.